Clinical trial
Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma
NCT05831787 is registered in ClinicalTrials.gov with ASH Research Collaborative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma
- Lead sponsor
- ASH Research Collaborative
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 23, 2024
- Completion date
- December 31, 2024
- Enrollment
- 201 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.